Integral Health Asset Management »

Merus N V shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.4M 165k 45.03

More positions owned by Integral Health Asset Management

Viking Therapeutics Put Option (VKTX)
Insmed Com Par $.01 (INSM)
Tenet Healthcare Corp Com New (THC)
Boston Scientific Corporation (BSX)
Cytokinetics Com New (CYTK)
Merck & Co (MRK)
Encompass Health Corp (EHC)
Walgreen Boots Alliance (WBA)
Anthem (ELV)
Abbvie (ABBV)
Universal Hlth Svcs CL B (UHS)
Novartis Sponsored Adr (NVS)
Tarsus Pharmaceuticals (TARS)
Moonlake Immunotherapeutics Class A Ord Call Option (MLTX)
Longboard Pharmaceuticals In (LBPH)

View all positions for Integral Health Asset Management

Top funds holding Merus N V

Commodore Capital
Federated Investors
Deerfield Management Company
Samlyn Capital
Wellington Management Company
Boxer Capital
Franklin Resources
VR Adviser
FMR
Lynx1 Capital Management
BlackRock
T. Rowe Price Associates
BVF
Medicxi Ventures Management
Rock Springs Capital Management

View all funds holding Merus N V